2019 Archived Content
OVERVIEW | DOWNLOAD BROCHURE | PLENARY SESSION | SHORT COURSES | TRAINING SEMINARS | ATTENDEES | BREAKOUT DISCUSSIONS
Short-Courses
symposia
training-seminars

2019-brochure-download-form


2019 Speakers

 

Adrian Bot

Adrian Bot
MD, PhD, Vice President, Translational Medicine, Kite, a Gilead Company

Stephen M. Hewitt

Stephen M. Hewitt
MD, PhD, CAPT, USPHS, Head, Experimental Pathology Laboratory, Laboratory of Pathology, Center for Cancer Research, NCI, NIH

Thomas Brown

Thomas Brown
MD, MBA, Executive Director, Swedish Cancer Institute; Co-Chair, PSJH Personalized Medicine Program, PSJH Cancer Leadership Council

Peter Henstock

Peter Henstock
PhD, AI & Machine Learning Lead, Pfizer

Mark Curran

Mark Curran
PhD, Vice President, Immunology, Head, Companion Diagnostics, Janssen R&D LLC

 
 

Phil Febbo

Phil Febbo
MD, CMO, Senior Vice President, Clinical Genomics, Illumina

John Fox

John Fox
MD, Vice President, Associate Chief Medical Officer, PriorityHealth

Sandor Szalma

Sandor Szalma
PhD, Global Head, Computational Biology, Takeda Pharmaceuticals

Tom Kaminski

Tom Kaminski
Senior Vice President, Corporate Strategy, LabCorp

Kathleen Kelly

Kathleen Kelly
PhD, Lab Chief, Laboratory of Genitourinary Cancer Pathogenesis, Center for Cancer Research, National Cancer Institute

 

View All Speakers

 

Funda Meric-Bernstam

Funda Meric-Bernstam
MD, Chair, Executive, Investigational Cancer Therapeutics, MD Anderson Cancer Center

Tim Stenzel

Tim Stenzel
MD, PhD, Director, Office of In Vitro Diagnostics and Radiological Health, Center for Devices and Radiological Health, U.S. FDA

David B. Roth

David B. Roth
MD, PhD, Director, Penn Center for Precision Medicine; Chair, Pathology and Laboratory Medicine, Perelman School of Medicine, UPenn

Andrea T. Norris

Andrea T. Norris
Director, NIH’s Center for IT, CIO, NIH, Department of Health and Human Services, NIH

Hakan Sakul

Hakan Sakul
PhD, Vice President and Head of Diagnostics, Pfizer

 
 

Anthony (Nino) Sireci

Anthony (Nino) Sireci
Medical Director, Diagnostics Lead, Medical Affairs, Loxo Oncology

David Smoley

David Smoley
CIO, AstraZeneca

Helen M. Moore

Helen M. Moore
PhD, Branch Chief, Biorepositories and Biospecimen Research Branch, NCI

Martin Stumpe

Martin Stumpe
PhD, Senior Vice President, Data Science, Tempus

Sara Gottfried

Sara Gottfried
MD, Chief Medical Officer, Metagenics; Author, Brain Body Diet (releasing March 2019) and Happy Self and Younger

 

View All Speakers

Testimonials

Quote about an annual must-attend meeting bridging industry and academic interests in Molecular Medicine, from the Chief Commercial Officer & GM of Silicon Biosystems.
Tri-Con brings diagnostics developers, payers, and researchers together for productive exchange on issues core to the growth of our industry. - Vice President, Product Management, DNA Genotek
The conversations we had in our booth were highly productive in comparison to other tradeshows we’ve attended this year. - VP of Bus Dev, Oasis Diagnostics
#TRICON
Submit a Speaker Proposal
Sponsorship Opportunities
Partnering and Networking

Conference Programs

May 4-5, 2026

Diagnostics Innovation

Artificial Intelligence

Precision Medicine